Think Bioscience Inc.
The University of Colorado Connection
is a ǸԹ-based synthetic biology company with strong roots at CU ǸԹ. The company was spun out of 's lab (CU ǸԹ Department of Chemical and Biological Engineering and BioFrontiers Institute), where its foundational technology, leveraging microbial systems to discover small-molecule drugs for previously “undruggable” targets, was developed. Its lead programs, including inhibitors of PTP1B, emerged directly from this academic research.
Funding Status and Investment Opportunities
- Industry Applications: Health and Wellness, Biotech, Therapeutics
- Funding Round: Series B
- Contact for Investment Inquiries: , jfox@thinkbioscience.com
In the News
- Colorado BioScience Association announces eight CU ǸԹ companies will present at 2026 Rocky Mountain Life Sciences Investor & Partnering Conference (2026, CBSA)
- Think Bioscience raises $55M in oversubscribed Series A (2026)
- Think Bioscience, a CU ǸԹ spinout, raises $26M to find ‘pockets’ for drug therapies (2024)
- Six CU ǸԹ startups selected to present at the Rocky Mountain Life Science Investor Conference (2024)
- Jerome Fox elevated to senior member of prestigious National Academy of Inventors (2024)
- CU ǸԹ spinout Think Bioscience raises $17M to target undruggable proteins (2022)
Venture Partners Programs
- Destination Startup (2022)
- Lab Venture Challenge(2020)
- Intellectual Property Management (2018)
Technology Development Funding
U.S. National Science Foundation (NSF)
This page was last updated on May 19, 2025. Please email vpnews@colorado.edu for corrections or updates
The Insider Investor eNewsletter
Media Inquiries
For marketing inquiries and news tips, contact Daniel Leonard,senior marketing and communications specialist for Venture Partners at CU ǸԹ.
For media inquiries, please visit .